PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Vertex surprised by FDA hold on diabetes trial

Trials for Vertex Pharmaceuticals' investigational stem cell-derived diabetes therapy have been halted by the U.S. FDA, taking the biotech by surprise...
Continue Reading →
News

Byondis and Medac link up to commercialise trastuzumab duocarmazine

Byondis and Medac link up to commercialise trastuzumab duocarmazine. Byondis and Medac have entered into a license and collaboration agreement for a form of targe...
Continue Reading →
News

Idorsia’s Quviviq approved for adults with chronic insomnia disorder

The EC’s decision on the insomnia treatment was supported by phase 3 trial results. Idorsia has announced that the European Commission (EC) has granted marketing ...
Continue Reading →
News

BMS wins first FDA approval for HCM drug

Bristol Myers Squibb has received the FDA nod for its potential-blockbuster heart disease drug. The agency’s decision was revealed last week, giving BMS...
Continue Reading →
News

FDA says ‘not yet’ to Praxis epilepsy drug

The FDA has placed a clinical hold on Praxis Precision Medicine’s new epilepsy drug. While the reasons have not been shared yet, according to a regulato...
Continue Reading →
News

SGS WINS FIVE CATEGORIES IN THE 2022 CRO LEADERSHIP AWARDS

SGS has again been rewarded for its industry-leading work, receiving five 2022 CRO Leadership Awards in the categories of Capabilities, Compatibility, Expertise, Qua...
Continue Reading →
News

ViGeneron and Daiichi Sankyo to develop therapy for eye diseases

Follow-on collaboration between ViGeneron and Daiichi Sankyo allows the companies to create and validate vgAAV-based therapeutic candidates ViGeneron and Daiichi ...
Continue Reading →
News

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

Cancer Research UK, the world’s largest independent funder of cancer research, today (Tuesday 26th), unveiled Cancer Research Horizons, its new and ambitious approac...
Continue Reading →
News

Healome Therapeutics to accelerate development for ocular disease

Studies have demonstrated that Healome’s formulations have anti-fibrotic activity and are augmented when combined with other therapeutics. The University of Birmi...
Continue Reading →
News

Gulf Pharmaceutical Industries Julphar Announces its Strategy 2030, with 100+ New Products to Drive Sustainable Growth

Julphar successfully completes its two-year strategic turnaround project by the end of 2021. Julphar launches its new project for transformational growth to purs...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026